Abstract
We describe the successful treatment of a 20-year-old patient with chronic granulomatous disease (CGD), by unrelated bone marrow transplantation (UBMT). The patient is relatively old compared to other CGD patients treated with BMT. He had had repeated serious infections from early childhood and was diagnosed as CGD, gp91-phox deficiency. Prolonged antibiotic-resistant pneumonitis worsened when the patient was 18 years old. In addition, he suffered Aspergillus osteomyelitis and acute renal failure due to amphotericin B. He received 94 granulocyte transfusions from 94 adult donors and the infections gradually improved. In September 1998, at 20 years of age, he underwent UBMT from an HLA 6 antigen-matched male donor, with CY and TBI conditioning. He received MTX and CsA as prophylaxis against GVHD. No serious complications occurred and rapid engraftment was achieved. Acute GVHD (grade 2, at day 19) and chronic GVHD (limited, at day 192) occurred. However, both were easily controlled. The patient is alive and well with no late rejection 26 months after UBMT. Bone Marrow Transplantation (2001) 28, 83–87.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
The study group of phagocyte disorders of Japan and M Hasui . Chronic granulomatous disease in Japan: incidence and natural history Pediatr Int 1999 41: 589–593
Mouy R, Fischer A, Vilmer E et al. Incidence, severity, and prevention of infections in chronic granulomatous disease J Pediatr 1989 114: 555–560
Finn A, Hadzic N, Morgan G et al. Prognosis of chronic granulomatous disease Arch Dis Child 1990 65: 942–945
Winkelstein JA, Marino MC, Johnston RB et al. Chronic granulomatous disease report on a national registry of 368 patients Medicine 2000 79: 155–169
Di Bartolomeo P, Di Girolamo G, Angrilli F et al. Reconstitution of normal neutrophil function in chronic granulomatous disease by bone marrow transplantation Bone Marrow Transplant 1989 4: 695–700
Zintl F, Hermann J, Fuchs D et al. Correction of fatal genetic diseases using bone marrow transplantation. 2 Kinderarztl Prax 1991 59: 10–15
Hobbs JR, Monteil M, McCluskey DR et al. Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor Eur J Pediatr 1992 151: 806–810
Ozsahin H, von Planta M, Muller I et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin B Blood 1998 92: 2719–2724
Ho CM, Vowels MR, Lockwood L et al. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease Bone Marrow Transplant 1996 18: 213–215
Calvino MC, Maldonado MS, Otheo E et al. Bone marrow transplantation in chronic granulomatous disease Eur J Pediatr 1996 155: 877–879
Akioka S, Itoh H, Ueda I et al. Donor lymphocyte infusion at unstable mixed chimerism in an allogenic BMT recipient for chronic granulomatous disease Bone Marrow Transplant 1998 22: 609–611
Leung TF, Chik KW, Li CK et al. Bone marrow transplantation for chronic granulomatous disease: long term follow-up and review of literature Bone Marrow Transplant 1999 24: 567–570
Perfect JR, Klotman ME, Gilbert CC et al. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients J Infect Dis 1992 165: 891–897
The Westminster Hospitals Bone-Marrow Transplant Team . Bone-marrow transplant from an unrelated donor for chronic granulomatous disease Lancet 1977 1: 210–213
Hobbs JR . Correction of 34 genetic diseases by displacement bone marrow transplantation Plasma Ther Transfus Technol 1985 6: 221–246
Jabado N, Deist FL, Cant A et al. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft Pediatrics 1996 98: 420–428
Fischer A, Landais P, Friedrich W et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European group for BMT and the European group for immunodeficiency Blood 1994 83: 1149–1154
Acknowledgements
We thank Prof Y Kobayashi, Dr S Taniuchi, A Yamamoto, M Hasui and S Tsuji (Dept of Pediatrics, Kansai Medical University) for performing the neutrophil function tests.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watanabe, C., Yajima, S., Taguchi, T. et al. Successful unrelated bone marrow transplantation for a patient with chronic granulomatous disease and associated resistant pneumonitis and Aspergillus osteomyelitis. Bone Marrow Transplant 28, 83–87 (2001). https://doi.org/10.1038/sj.bmt.1703086
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703086
Keywords
This article is cited by
-
Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease
Immunologic Research (2009)
-
Advances in treatment for chronic granulomatous disease
Immunologic Research (2009)
-
Sequential reduced- and full-intensity allografting using same donor in a child with chronic granulomatous disease and coexistent, significant comorbidity
Bone Marrow Transplantation (2004)
-
Granulocyte transfusions in the G-CSF era. Where do we stand?
Bone Marrow Transplantation (2004)
-
Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature
Annals of Hematology (2003)